ARTICLE | Clinical News
Cerestat aptiganel: Phase III results; discontinued
December 10, 2001 8:00 AM UTC
Researchers published in the Journal of the American Medical Association results from a study that was discontinued in 1997. In an interim analysis of an international placebo-controlled Phase II/III ...